WASHINGTON (AP) _ Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $604,000 in its fourth quarter.
The Washington-based company said it had a loss of 1 cent per share. Earnings, adjusted for amortization costs and stock option expense, came to 8 cents per share.
The biopharmaceutical company posted revenue of $38.2 million in the period.
For the year, the company reported that its loss narrowed to $18 million, or 41 cents per share. Revenue was reported as $146 million.
Vanda expects full-year revenue in the range of $165 million to $175 million.
Vanda shares have fallen 9 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $14.50, a climb of 77 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VNDA at https://www.zacks.com/ap/VNDA
Keywords: Vanda Pharmaceuticals, Earnings Report